As on February 18, 2021, CorMedix Inc. (NASDAQ: CRMD) got off with the flyer as it spiked 13.32% to $16.25. During the day, the stock rose to $16.324 and sunk to $14.54 before settling in for the price of $14.34 at the close. Taking a more long-term approach, CRMD posted a 52-week range of $2.16-$17.14.
The Healthcare sector firm’s twelve-monthly sales growth has been 8.40% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 17.80%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -19.70%. This publicly-traded company’s shares outstanding now amounts to $32.13 million, simultaneously with a float of $29.91 million. The organization now has a market capitalization sitting at $505.54 million. At the time of writing, stock’s 50-day Moving Average stood at $9.77, while the 200-day Moving Average is $6.52.
It is quite necessary to find out the efficiency of the corporate organization, which has 30 number of employees on its payroll. It has generated 9,442 per worker during the last fiscal year. Meanwhile, its income per employee was -547,769. The stock had 51.79 Receivables turnover and 0.01 Total Asset turnover. For the Profitability, stocks gross margin was -57.63, operating margin was -7416.31 and Pretax Margin of -7587.87.
CorMedix Inc. (CRMD) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. CorMedix Inc.’s current insider ownership accounts for 1.90%, in contrast to 27.00% institutional ownership. According to the most recent insider trade that took place on Sep 04, this organization’s Director bought 5,715 shares at the rate of 3.99, making the entire transaction reach 22,816 in total value, affecting insider ownership by 60,498. Preceding that transaction, on Sep 03, Company’s Chief Financial Officer bought 1,150 for 4.07, making the whole transaction’s value amount to 4,681. This particular insider is now the holder of 1,150 in total.
CorMedix Inc. (CRMD) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 9/29/2020, the company posted -$0.22 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.25) by $0.03. This company achieved a net margin of -5801.29 while generating a return on equity of -114.99. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.
CorMedix Inc.’s EPS decrease for this current 12-month fiscal period is -19.70% and is forecasted to reach -0.99 in the upcoming year.
CorMedix Inc. (NASDAQ: CRMD) Trading Performance Indicators
Let’s observe the current performance indicators for CorMedix Inc. (CRMD). It’s Quick Ratio in the last reported quarter now stands at 8.40. The Stock has managed to achieve an average true range (ATR) of 1.23. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2527.69.
In the same vein, CRMD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.79, a figure that is expected to reach -0.23 in the next quarter, and analysts are predicting that it will be -0.99 at the market close of one year from today.
Technical Analysis of CorMedix Inc. (CRMD)
Through scrutinizing the latest numbers posted by the [CorMedix Inc., CRMD], it can be observed that its last 5-days Average volume of 1.26 million was better the volume of 1.08 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 52.96% While, its Average True Range was 1.37.
Raw Stochastic average of CorMedix Inc. (CRMD) in the period of the previous 100 days is set at 92.73%, which indicates a major rise in contrast to 89.70% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 158.86% that was higher than 85.50% volatility it exhibited in the past 100-days period.